In addition, PABPN1 aggregates or the process of aggregation are likely to substantially contribute to the pathology since decreasing the aggregation load, for example following oral treatments with small compounds, improve muscle function in Drosophila and mouse models of OPMD [28–32]. Here, PABPN1 is linked to oculopharyngeal muscular dystrophy.